Medidata NEXT
AI for Impact
Go beyond the hype. Experience firsthand how AI is revolutionizing clinical research across pharma, biotech, and medtech.
Why Attend
NEXT is the bridge. AI is the breakthrough.
And you belong in the room as we tackle the most pivotal shift in life sciences: moving from AI that’s abstract to AI that drives impact.
Meet the industry leaders paving the way for AI adoption at scale across clinical trials. Take your seat alongside sponsors, CROs, site teams, patient advocates, analysts, researchers, and more.
- Learn how top organizations are using AI to speed study timelines, reduce risk, and make smarter decisions
- Get your hands on the latest AI-driven tech that’s achieving tangible results
- Collaborate with your colleagues and exchange ideas during dedicated networking opportunities
The industry’s shifting in real time. Don’t wait for the recap—be here while it happens.
Registration is free for our customers and qualified members of the life sciences community.
NEXT by the Numbers
Attendees
Companies
Sessions
Cities
The Medidata NEXT Innovation Series
We’re bringing the premier clinical trials conference experience to customers worldwide. Find a location near you below.
Testimonials
“What I love is walking the exhibit floor and seeing the different tools that Medidata and partners have incorporated. I also love the sessions. The combination of looking at what the product is and hearing some of the trends in the industry really make it a valuable day.”
– Bunny Ellerin, Co-founder & CEO, Digital Health New York
“It’s been brilliant. I’ve learned what developments the company’s working on, and some of them are quite amazing, especially integration of the AI and machine learning into the system, which will allow you to analyze the data on an ongoing basis and propose solutions on the spot.”
– Dilshat Djumanov, Director of Data Science, Richmond Pharmacology (CRO)
“Excellent opportunity to interact with Medidata SMEs and learn about new offerings.”
– Susie Giroux, Sr. Clinical Database Developer, BioMarin Pharmaceutical, Inc.
